Throughout the month of May, the Lupus Foundation of America is encouraging people living with lupus, friends, family members ...
That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...
The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for ...
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ...
AstraZeneca’s SAPHNELO® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen, for the treatment of adult patients with systemic lupus ...
David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck KGaA, Darmstadt, Germany ...
Weight-based dosing misses accounting for factors such as chronic kidney disease or chronic transaminitis, which could ...
Anifrolumab-fnia, an IFNAR1-blocking monoclonal antibody, is now authorized for weekly subcutaneous self-administration in ...
AstraZeneca’s Saphnelo approved in US for subcutaneous self-administration as a new autoinjector to treat systemic lupus erythematosus: Cambridge, UK Tuesday, April 28, 2026, 10 ...
AstraZeneca's Saphnelo (anifrolumab) has been approved in the US for self-administration as a once-weekly autoinjector, the Saphnelo Pen, for the ...
Emirates News Agency on MSN
UAE strengthens its position in regenerative medicine, stem cell therapies
ABU DHABI, 3rd May, 2026 (WAM) -- The United Arab Emirates is continuing to strengthen its position in regenerative medicine and stem cell therapies, reinforcing its role as a regional and global hub ...
Rare Beauty, Refy and Clarins are among the brands bringing fresh packaging innovation to the complexion category, which has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results